Atrophic gastritis
Atrophic gastritis refers to a pathological state in which the gastric mucosa becomes thinner and the intrinsic glands decrease due to various causes. Its onset may be a long, multi-stage, multi-gene mutation accumulation process with the combined effects of multiple causes. Chronic gastritis recurrently causes atrophy and intestinal metaplasia of the gastric mucosal glands, and some glands may develop atypical hyperplasia or develop into cancer. This disease is more common in the elderly. Although atrophic gastritis is a precancerous lesion, cancer is closely related to dysplasia. Therefore, atrophy without obvious dysplasia has no obvious tendency to cancer.
-
Site of disease:
Stomach -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Upper abdominal discomfort upper abdominal pain loss of appetite abdominal distension atrophic changes in gastric mucosa
Related Drugs
Armillariin A Tablets
Indication: Acute cholecystitis, acute exacerbation of chronic cholecystitis, chronic superficial gastritis and chronic superficial atrophic gastritis.
Manufacturer:
Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
Armillariin A Tablets
Indication: It is suitable for acute cholecystitis, acute attack of chronic cholecystitis, chronic superficial gastritis and chronic superficial atrophic gastritis.
Manufacturer:
Nanjing Pharmaceutical FACTORY Co., Ltd.
Armillariin A Tablets
Indication: It is suitable for acute cholecystitis, acute attack of chronic cholecystitis, chronic superficial gastritis and chronic superficial atrophic gastritis.
Manufacturer:
Topfond Pharmaceutical Co., Ltd.
Armillariin A Tablets
Indication: It is suitable for acute cholecystitis, acute attack of chronic cholecystitis, chronic superficial gastritis and chronic superficial atrophic gastritis.
Manufacturer:
Yunpeng Pharmaceutical Group Co., Ltd.
Armillariin A Tablets
Indication: It is suitable for acute cholecystitis, acute attack of chronic cholecystitis, chronic superficial gastritis and chronic superficial atrophic gastritis.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Armillariin A Tablets
Indication: It is suitable for acute cholecystitis, acute attack of chronic cholecystitis, chronic superficial gastritis and chronic superficial atrophic gastritis.
Manufacturer:
Sinopharm Zhonglian Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Dezhou Bocheng Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Gansu Lanyao Pharmaceutical Co., Ltd.
Vitazyme Capsules
Indication: At present, it is mainly used to treat atrophic gastritis, superficial gastritis, esophageal epithelial cell hyperplasia, and prevent cancer caused by cell hyperplasia. It can also be used as an auxiliary treatment for various types of hepatitis and riboflavin deficiency.
Manufacturer:
Jingfukang Pharmaceutical Group Chifeng Danlong Pharmaceutical Co., Ltd.
Related Ingredients
-
Armillarisin A list
53696-74-5 -
6-Formyllimetin list
915764-62-4 -
Riboflavin list
83-88-5 -
Vitamin E list
2074-53-5 -
L-tert-Leucine list
20859-02-3